Interview with André Bràzay, President, Sandoz Hungary
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
Address: Bartók Béla út 43-47 H-1114 Budapest,Hungary
Tel: +36 1 430 28 90
Web: http://www.sandoz.hu/site/hu/index.shtml
The Sandoz Pty Ltd ‘s mission pillars, goals, aspirations, our values match, the international principles of Sandoz.
It is our fundamental duty is to our products, our activities improve our lives. To that end, patent medicines from leaving active gyógyszerösszetevőket, a wide range of biotechnology products developed, manufactured and sold at an affordable price, but meeting the highest standards of quality.
During our activities we have created a value system that gives all our partners, our customers continuously expect the highest standards of serving. The world’s leading generic manufacturer of the task we facilitate access to medical care, and health care systems támogatását.Tesszük all aware of the responsibility which the market maker requires.
The Sandoz social responsibility committed, so seek him, that of our long-term, sustainable, economic, social and environmental aspects.
The company’s philosophy of most of the high quality, global presence and innovation in threes we legtömörebben summarized.
The high quality standards by Sandoz in the ever-increasing customer demands are fully met aims itself.
A global presence provides Sandoz for a uniform, international business, as in other countries experienced positive trends, and immediately at the national market .
The innovation – paradoxically – Sandoznál tradition. Our product range is a continuous expansion of committed ourselves to ensuring that our clients always know the latest products and technologies provide.
The Sandoz Hungaria Ltd. we are committed to earn our unreserved confidence. To this end, the company’s global experience and innovative approach we use the best quality, unique products and services we provide. Our goal is to earn customer trust, and they regarded us as a generic drug manufacturers the most customer-oriented company of.
Sandoz Hungaria Ltd. continuously monitor our clients’ changing needs and strive to creativity and innovative approach to these needs as possible to able to answer.
Therapeutic Areas
Market-leading product portfolio (so-called ‘blockbuster’) and fill gaps in its niche market for both drugs include all major therapeutic areas, in particular:
Antibiotics
Cardiovascular
Central Nervous System
Stomach and digestive tract
Osteoporosis
Dermatology
Allergy
Oncology
Muscle and skeletal
Urology
Top 5 products containing active worldwide
Fentanyl
Omeprazole
Amoxicillin-clavulanate
Metoprolol
Simvastatin
Taking a look at the voices of the pharmaceutical industry in Hungary, we see AIPM and MAYGOSZ as the 2 key associations. And while MAGYOSZ already represents many generic players……
Dr Miklós Kellermayer elaborates on his priorities to implement a more practical, experience-focused curriculum as the recently appointed Dean of the Faculty of Medicine of Semmelweis University. Dr Kellermayer goes…
Veronika Ferencz, general manager of Exeltis Hungary, gives an update on the recent activies and achievement of the affiliate since her last PharmaBoardroom interview in 2016. Furthermore, Ferencz goes on…
István Hodász, CEO of Egis Pharmaceuticals PLC, introduces the longstanding history of the company and its positioning as a leading manufacturer of value-added generics with a strong presence in the…
Prof. Éva Szökő, president of the Hungarian Society for Pharmaceutical Sciences (MGYT), shares her insights on the activities of the society, its collaboration with institutions and industry players in the…
Jānis Meikšāns, newly appointed general manager of Teva Hungary, speaks about his first few months in the country. Meikšāns goes on to elaborate on Hungary’s key positioning as a strategic…
Dr Mátyás Szentiványi, Director General of the National Institute of Pharmacy and Nutrition (OGYEI), introduces the administrative authority and specifies his strategy to be an increasingly collaborative and communicative body…
Dr. Péter Ofner, Former Director of the Gottsegen Hungarian Insititute of Cardiology, shares his insights on the cardiological capabilities of the institute, the epidemiological profile of the country, the collaborations…
Dr. György Blaskó, former President and Chairman of the Hungarian European Clinical Research Infrastructure Network, explains the role of the research network, the impact it has on the Hungarian clinical…
Dr. György Bagdy, professor and former vice rector at Semmelweis University, shares his insights on the longstanding history of pharmacology in Hungary, the key strengths of the country in the…
Hungarian national champion Egis and French Big Pharma Sanofi have both made recent big-ticket investments in new facilities in Hungary. Egis’ new manufacturing plant in Körmend and Sanofi’s new shared…
Dr. József Mandl, President of the Medical Research Council (ETT), discusses the role of the council, the research environment in Hungary, its relationship with the European Clinical Research Infrastructure Network…
Júlia Lipovecz, director of Swisscham Hungary, shares insights into the association and its activities to promote Swiss foreign investment in Hungary, the importance of local collaboration, and how its members…
See our Cookie Privacy Policy Here